Clinical Trials Directory

Trials / Terminated

TerminatedNCT01247649

Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AG

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The present study is aimed to evaluate the feasibility of a new noninvasive method to measure continuous glucose values using electromagnetic radiation.

Detailed description

The non invasive continuous glucose sensing system of Physical Logic is based on a vector network analyzer (VNA), which monitor blood glucose through propriety sensors.Dielectric spectroscopy is an analytical technique whereby the electromagnetic radiation is affected by the electric dipole moment of the sample it interacts with. This method utilizes the change in the impedance of the antenna to measure the change in the relaxation processes of the interrogated medium. The VNA (vector network analyzer) , which emits non irradiating electromagnetic waves in very low power emission, is connected via standard coaxial cables to propriety sensors that are attached to the patient skin without direct contact. Study objective: To evaluate the feasibility of a new noninvasive method to measure continuous glucose values using electromagnetic radiation.The glucose values generated by the investigational non invasive devise will be compared to glucose reading of a reference devise, which measure blood glucose levels at the subcutaneous tissue. During the study we will evaluate the reliability of the study device under the conditions of alter blood glucose values in the range of 50-400 mg/dl:

Conditions

Interventions

TypeNameDescription
DEVICEPhysical Logic Continuous Glucose Monitoring SystemPatients will be monitored to assess continuous blood glucose levels using the study device (Physical Logic) and reference methods, during 2-3 clinic visits, lasting 6-8 hours each

Timeline

Start date
2010-11-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2010-11-24
Last updated
2012-11-20

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01247649. Inclusion in this directory is not an endorsement.